利巴韦林联用盐酸氨溴索治疗50例病毒性肺炎的临床疗效分析

Study on the Clinical Effect of Ribavirin Combined with Ambroxoi Hydrochloride on 50 patients with Viral Pneumonia

目的探讨利巴韦林联合盐酸氨溴索对病毒性肺炎的临床疗效，为临床用药提供参考。方法在尊重患者意愿的基础上，将收治的100例病毒性肺炎患者分为联合治疗组和盐酸氨溴索组各50例。联合治疗组患者使用利巴韦林联合盐酸氨溴索进行治疗，盐酸氨溴索组使用盐酸氨溴索进行治疗。疗程结束后严格记录两组患者的各项生理指标，对两种用药方案的疗效、安全性进行分析比较。结果联合治疗组的临床总有效率、安全性分别高达96％、96％，远远高于盐酸氨溴索，两组差异有统计学意义（P〈0．05）。结论利巴韦林联合盐酸氨溴索治疗病毒性肺炎具有高效、安全的特点，是一种值得在临床上大力推广应用的联合用药方案。

Objective To discuss the clinical effect of ribavirin combined with ambroxol hydrochloride（AH） on viral pneumonia（VP） ,and to provide reference for clinical therapy. Methods One hundred cases of VP were divided into combined treatment group and AH group randomly（each group 50 cases）according to patients＇ willingness. The combined treatment group was treated with ribavirin combined with AH,while the AH group was treated with AH. The physical signs of two groups were strictly recorded after treatment, the clinical effect and safety of two treatment methods were comparatively analyzed. Results The total clinical effect and safety of combined treatment group reached to 96% and 96% ,which was obviously superior to AH group（P〈0.05）. Conclusion Ribavirin combined with AH has a significant effect and safety on VP treatment,which is worth to be rigorously promoted in clinical therapy.